Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
On Mar. 24, 2026, Pfizer and Valneva announced topline results from the Phase 3 VALOR “Vaccine Against Lyme…
-
-
VCU researchers find explosive rise in tick-linked meat allergy across the U.S.
On Oct. 30, 2025, researchers at Virginia Commonwealth University and VCU Health announced preliminary study findings that show…
-
Valneva and Pfizer announced a collaboration to co-develop and commercialize Lyme disease vaccine
On Apr. 30, 2020, Valneva and Pfizer announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine…
